Insider Transactions Reported by 14 Insiders of Fresh Tracks Therapeutics, Inc.

Location
Boulder, CO

There are no Buy or Sell transactions made by insiders since 12 Mar 2025

Fresh Tracks Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Exploration Capital, LLC 10%+ Owner $1,635,047 07 Jun 2024
Exploration Capital Fund, LP 10%+ Owner $693,000 04 Dec 2023
Andrew D. Sklawer President and CEO $38,876 02 Oct 2023
Deepak Chadha Former Chief R&D Officer & COO $22,091 01 Sep 2023
David R. McAvoy Gen Counsel, CCO, & Secretary $16,207 02 Oct 2023
Jose Breton Chief Accounting Officer 05 May 2022
VERU DENNISON T. Director 17 May 2022
Robert Busard Brown Chief Executive Officer, Director 05 May 2022
GARY A. LYONS Director 17 May 2022
VIJAY B. SAMANT Director 17 May 2022
REGINALD L. HARDY CHAIRMAN OF THE BOARD, Director 17 May 2022
Monica E. Luchi Chief Medical Officer 05 May 2022
Aaron Fox-Collis VP of Finance & CAO 28 Dec 2023
Albert N. Marchio II CEO and CFO, Director 28 Dec 2023

Recent Insider Transactions by Companies or Individuals for Fresh Tracks Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.